Sep 11, 2026 08:45AM
Sep 10, 2026 08:15AM
Sep 10, 2026 08:15AM
Aug 19, 2026 06:45AM
Aug 18, 2026 09:01AM
Aug 18, 2026 09:00AM
Jul 20, 2026 09:01AM FDA grants fast track status to Oncolytics' pelareorep for anal cancer
Jul 20, 2026 09:00AM
Jul 14, 2026 07:00AM
Jul 13, 2026 09:01AM
Jul 13, 2026 09:00AM
Jun 16, 2026 09:00AM
Jun 16, 2026 09:00AM
Jun 2, 2026 09:00AM Oncolytics Biotech adds Steve Glover to board, promotes John McAdory to COO
Jun 2, 2026 09:00AM
Jun 1, 2026 09:03AM
Jun 1, 2026 09:00AM
May 26, 2026 06:59AM
May 22, 2026 09:00AM
May 14, 2026 10:55AM
May 14, 2026 10:55AM "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
May 4, 2026 09:00AM
Apr 27, 2026 08:10AM
Apr 27, 2026 08:10AM
Apr 10, 2026 06:49AM
Apr 6, 2026 09:00AM
Apr 6, 2026 09:00AM
Apr 1, 2026 09:02AM Oncolytics Biotech completes incorporation change from Canada to Nevada
Apr 1, 2026 09:00AM
Mar 19, 2026 11:00AM
Mar 19, 2026 09:00AM
Mar 2, 2026 09:02AM
Mar 2, 2026 09:00AM
Feb 24, 2026 09:01AM
Feb 24, 2026 09:00AM Oncolytics Biotech® to Prioritize Registration-Focused Programs in Anal and Colorectal Cancer
Feb 17, 2026 10:48AM
Feb 5, 2026 09:26AM
Feb 4, 2026 08:50AM
Feb 4, 2026 08:50AM
Jan 15, 2026 04:01PM
Jan 14, 2026 10:39AM
Jan 14, 2026 09:00AM Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics
Jan 12, 2026 10:14AM
Jan 12, 2026 09:01AM
Jan 12, 2026 09:00AM
Jan 9, 2026 09:02AM
Jan 9, 2026 09:00AM
Jan 8, 2026 12:08PM
Jan 8, 2026 09:02AM Oncolytics Biotech files patent application to extend pelareorep protection
Jan 8, 2026 09:00AM

331,677 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All